Mitinab 400 mg Tablet
  1. Home
  2. Pharma Products
  3. Glenmark Pharmaceuticals Ltd
  4. Mitinab 400 mg Tablet

Mitinab 400 mg Tablet

Mitinab 400 mg Tablet contains imatinib mesylate 400 mg and is an oral targeted anticancer medicine used for certain blood cancers and gastrointestinal stromal tumors. It is taken by mouth with food and a large glass of water according to the prescribed treatment plan. Imatinib works by blocking specific tyrosine kinase proteins that contribute to abnormal cancer-cell growth.

BUY NOW

Category

Mitinab belongs to the tyrosine kinase inhibitor class and is used in appropriate treatment regimens for conditions such as chronic myeloid leukemia and gastrointestinal stromal tumors. It inhibits proteins including BCR-ABL and KIT, which are involved in the growth and survival of certain abnormal cells. The dosage and duration of treatment depend on the specific cancer, disease stage, and response to therapy. Regular blood counts and liver-function tests may be required during treatment to monitor for adverse effects.

Technical Specification

Specification Details
Active Ingredient Imatinib Mesylate
Strength 400 mg
Dosage Form Tablet
Route of Administration Oral
Therapeutic Class Antineoplastic
Drug Class Tyrosine Kinase Inhibitor

Product Also Known As

Mitinab 400mg Tablet, Mitinab 400 mg Tablet, Imatinib Mesylate 400mg Tablet, Imatinib 400mg Tablet, Imatinib Mesylate Tablet 400mg, Imatinib Tyrosine Kinase Inhibitor Tablet